Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials

K. Fizazi, T. W. Flaig, M. Stöckle, H. I. Scher, J. S. de Bono, D. E. Rathkopf, C. J. Ryan, T. Kheoh, J. Li, M. B. Todd, T. W. Griffin, A. Molina, C. H. Ohlmann

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences